Trending...
- California: Governor Newsom responds to DOGE's dismantling of AmeriCorps: 'Middle finger to volunteers. We will sue'
- 100 days after the fires: California and Los Angeles rebuild, recover, and rise together
- California: Governor Newsom announces appointments 4.18.25
SAN DIEGO - Californer -- Human Asialoglycoprotein Receptor 1 Extracellular Domain (recombinant)
Human Asialoglycoprotein Receptor 1 Extracellular Domain (recombinant) is a high quality protein that is produced using genetic engineering techniques. This protein is a part of the human asialoglycoprotein receptor 1, which is a cell surface receptor involved in the recognition and clearance of glycoproteins from the bloodstream. The extracellular domain of this receptor is the part of the protein that is located outside of the cell and is responsible for binding to specific ligands. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
Human Asialoglycoprotein Receptor 1 Extracellular Domain (recombinant)
Catalog number: B2016799
Lot number: Batch Dependent
Expiration Date: Batch dependent
More on The Californer
Amount: 50 µg
Molecular Weight or Concentration: 28.8 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -80°C
Keywords: ASGPR1, ASGR1, C-type Lectin Domain Family 4 Member H1, CLEC4H1, Hepatic Lectin H1
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1: Wymann S, Mischnik M, Leong D, Ghosh S, Tan X, Cao H, Kuehnemuth B, Powers GA, Halder P, de Souza MJ, James HS, Tomasetig V, Lind H, Rossato P, Owczarek CM, Ow SY, Dower SK, Baz Morelli A, Rowe T, Hardy MP. Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivo Biochem J. 2022 May 13;479(9):1007-1030.
https://moleculardepot.com/product/human-asialoglycoprotein-receptor-1-extracellular-domain-recombinant/
Human Asialoglycoprotein Receptor 1 Extracellular Domain (recombinant) is a high quality protein that is produced using genetic engineering techniques. This protein is a part of the human asialoglycoprotein receptor 1, which is a cell surface receptor involved in the recognition and clearance of glycoproteins from the bloodstream. The extracellular domain of this receptor is the part of the protein that is located outside of the cell and is responsible for binding to specific ligands. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
Human Asialoglycoprotein Receptor 1 Extracellular Domain (recombinant)
Catalog number: B2016799
Lot number: Batch Dependent
Expiration Date: Batch dependent
More on The Californer
- Lyricalmar Set To Release Powerful New Ep "MARCHIVES" May 16
- Charleston, SC - ACSEC offers Rain Barrels Through Annual Program
- HAVAS CHICAGO APPOINTS FRANK DATTALO AS CHIEF CREATIVE OFFICER
- Greek Government Issues Landmark Ministerial Order Addressing Citizenship of Greek-born adoptees
- Stout Surpasses 60,000 Acres and 3 Billion Plants Scanned
Amount: 50 µg
Molecular Weight or Concentration: 28.8 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -80°C
Keywords: ASGPR1, ASGR1, C-type Lectin Domain Family 4 Member H1, CLEC4H1, Hepatic Lectin H1
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1: Wymann S, Mischnik M, Leong D, Ghosh S, Tan X, Cao H, Kuehnemuth B, Powers GA, Halder P, de Souza MJ, James HS, Tomasetig V, Lind H, Rossato P, Owczarek CM, Ow SY, Dower SK, Baz Morelli A, Rowe T, Hardy MP. Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivo Biochem J. 2022 May 13;479(9):1007-1030.
https://moleculardepot.com/product/human-asialoglycoprotein-receptor-1-extracellular-domain-recombinant/
Source: Molecular Depot
0 Comments
Latest on The Californer
- Introducing the Heart-Shaped Pearl Earrings — A Romantic New Addition from Sairahaz Jewelers
- Personalized Name Necklaces Under $200 — The Perfect Gift for Any Occasion
- City of Long Beach to Host and Fund 2025 Pride Parade, Announces Grand Marshals
- California: Governor Newsom announces appointments 4.23.25
- California is now the 4th largest economy in the world
- DOJ Dismisses Charges Against Stephen Stepaniuk, MEDICAL LEGAL EVALUATORS and SAFETY WORKS
- Renata Simril, President & CEO of the LA84 Foundation, to Receive THE MUSES of the California Science Center Foundation 2025 Woman of the Year Award
- California: TOMORROW: Governor Newsom joins CAL FIRE to announce an expansion of world's largest aerial firefighting force
- Snell & Wilmer Partner Keith Gregory Named a Top 100 Lawyer & Champion of Mentorship by the LABJ
- Snell & Wilmer Partners Rose Sorensen & Douglas Thompson Named 2025 Legal Visionaries by L.A. Times
- Fairfield Inn by Marriott Scottsdale Old Town Opens
- 1,000 more clean school buses coming soon to California roads as state sees big demand for zero-emission buses and trucks
- 39th Annual California Strawberry Festival—Strawberry Treats And Family Fun
- Silva Construction Gives Advice on Home Remodeling Trends for 2025
- BKM's Senior Managing Director of Operations, Susan Rounds, and Associate Director of Design, Koren Mercer, Honored as 2025 Women of Influence
- Governor Newsom announces SUN Bucks Program will provide food to California kids during summer break 2025
- California: Governor Newsom's investment to prevent and prosecute organized retail crime yields 14,133 prosecution case referrals
- Long Beach Gears Up to Celebrate National Bike Month 2025
- Dreame Technology Expands US Footprint with New San Diego Location
- Pelican Reef Group Announces Grand Opening of New High Point Showroom – IHFC Building H-621 & Event April 27th, 2025